Cargando…

Prevention of Mother-To-Child Transmission of HIV: Cost-Effectiveness of Antiretroviral Regimens and Feeding Options in Rwanda

BACKGROUND: Rwanda's National PMTCT program aims to achieve elimination of new HIV infections in children by 2015. In November 2010, Rwanda adopted the WHO 2010 ARV guidelines for PMTCT recommending Option B (HAART) for all HIV-positive pregnant women extended throughout breastfeeding and disco...

Descripción completa

Detalles Bibliográficos
Autores principales: Binagwaho, Agnes, Pegurri, Elisabetta, Drobac, Peter C., Mugwaneza, Placidie, Stulac, Sara N., Wagner, Claire M., Karema, Corine, Tsague, Landry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3577801/
https://www.ncbi.nlm.nih.gov/pubmed/23437040
http://dx.doi.org/10.1371/journal.pone.0054180
_version_ 1782259975768244224
author Binagwaho, Agnes
Pegurri, Elisabetta
Drobac, Peter C.
Mugwaneza, Placidie
Stulac, Sara N.
Wagner, Claire M.
Karema, Corine
Tsague, Landry
author_facet Binagwaho, Agnes
Pegurri, Elisabetta
Drobac, Peter C.
Mugwaneza, Placidie
Stulac, Sara N.
Wagner, Claire M.
Karema, Corine
Tsague, Landry
author_sort Binagwaho, Agnes
collection PubMed
description BACKGROUND: Rwanda's National PMTCT program aims to achieve elimination of new HIV infections in children by 2015. In November 2010, Rwanda adopted the WHO 2010 ARV guidelines for PMTCT recommending Option B (HAART) for all HIV-positive pregnant women extended throughout breastfeeding and discontinued (short course-HAART) only for those not eligible for life treatment. The current study aims to assess the cost-effectiveness of this policy choice. METHODS: Based on a cohort of HIV-infected pregnant women in Rwanda, we modelled the cost-effectiveness of six regimens: dual ARV prophylaxis with either 12 months breastfeeding or replacement feeding; short course HAART (Sc-HAART) prophylaxis with either 6 months breastfeeding, 12 months breastfeeding, or 18 months breastfeeding; and Sc-HAART prophylaxis with replacement feeding. Direct costs were modelled based on all inputs in each scenario and related unit costs. Effectiveness was evaluated by measuring HIV-free survival at 18 months. Savings correspond to the lifetime costs of HIV treatment and care avoided as a result of all vertical HIV infections averted. RESULTS: All PMTCT scenarios considered are cost saving compared to “no intervention.” Sc-HAART with 12 months breastfeeding or 6 months breastfeeding dominate all other scenarios. Sc-HAART with 12 months breastfeeding allows for more children to be alive and HIV-uninfected by 18 months than Sc-HAART with 6 months breastfeeding for an incremental cost per child alive and uninfected of 11,882 USD. This conclusion is sensitive to changes in the relative risk of mortality by 18 months for exposed HIV-uninfected children on replacement feeding from birth and those who were breastfed for only 6 months compared to those breastfeeding for 12 months or more. CONCLUSION: Our findings support the earlier decision by Rwanda to adopt WHO Option B and could inform alternatives for breastfeeding duration. Local contexts and existing care delivery models should be part of national policy decisions.
format Online
Article
Text
id pubmed-3577801
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-35778012013-02-22 Prevention of Mother-To-Child Transmission of HIV: Cost-Effectiveness of Antiretroviral Regimens and Feeding Options in Rwanda Binagwaho, Agnes Pegurri, Elisabetta Drobac, Peter C. Mugwaneza, Placidie Stulac, Sara N. Wagner, Claire M. Karema, Corine Tsague, Landry PLoS One Research Article BACKGROUND: Rwanda's National PMTCT program aims to achieve elimination of new HIV infections in children by 2015. In November 2010, Rwanda adopted the WHO 2010 ARV guidelines for PMTCT recommending Option B (HAART) for all HIV-positive pregnant women extended throughout breastfeeding and discontinued (short course-HAART) only for those not eligible for life treatment. The current study aims to assess the cost-effectiveness of this policy choice. METHODS: Based on a cohort of HIV-infected pregnant women in Rwanda, we modelled the cost-effectiveness of six regimens: dual ARV prophylaxis with either 12 months breastfeeding or replacement feeding; short course HAART (Sc-HAART) prophylaxis with either 6 months breastfeeding, 12 months breastfeeding, or 18 months breastfeeding; and Sc-HAART prophylaxis with replacement feeding. Direct costs were modelled based on all inputs in each scenario and related unit costs. Effectiveness was evaluated by measuring HIV-free survival at 18 months. Savings correspond to the lifetime costs of HIV treatment and care avoided as a result of all vertical HIV infections averted. RESULTS: All PMTCT scenarios considered are cost saving compared to “no intervention.” Sc-HAART with 12 months breastfeeding or 6 months breastfeeding dominate all other scenarios. Sc-HAART with 12 months breastfeeding allows for more children to be alive and HIV-uninfected by 18 months than Sc-HAART with 6 months breastfeeding for an incremental cost per child alive and uninfected of 11,882 USD. This conclusion is sensitive to changes in the relative risk of mortality by 18 months for exposed HIV-uninfected children on replacement feeding from birth and those who were breastfed for only 6 months compared to those breastfeeding for 12 months or more. CONCLUSION: Our findings support the earlier decision by Rwanda to adopt WHO Option B and could inform alternatives for breastfeeding duration. Local contexts and existing care delivery models should be part of national policy decisions. Public Library of Science 2013-02-20 /pmc/articles/PMC3577801/ /pubmed/23437040 http://dx.doi.org/10.1371/journal.pone.0054180 Text en © 2013 Binagwaho et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Binagwaho, Agnes
Pegurri, Elisabetta
Drobac, Peter C.
Mugwaneza, Placidie
Stulac, Sara N.
Wagner, Claire M.
Karema, Corine
Tsague, Landry
Prevention of Mother-To-Child Transmission of HIV: Cost-Effectiveness of Antiretroviral Regimens and Feeding Options in Rwanda
title Prevention of Mother-To-Child Transmission of HIV: Cost-Effectiveness of Antiretroviral Regimens and Feeding Options in Rwanda
title_full Prevention of Mother-To-Child Transmission of HIV: Cost-Effectiveness of Antiretroviral Regimens and Feeding Options in Rwanda
title_fullStr Prevention of Mother-To-Child Transmission of HIV: Cost-Effectiveness of Antiretroviral Regimens and Feeding Options in Rwanda
title_full_unstemmed Prevention of Mother-To-Child Transmission of HIV: Cost-Effectiveness of Antiretroviral Regimens and Feeding Options in Rwanda
title_short Prevention of Mother-To-Child Transmission of HIV: Cost-Effectiveness of Antiretroviral Regimens and Feeding Options in Rwanda
title_sort prevention of mother-to-child transmission of hiv: cost-effectiveness of antiretroviral regimens and feeding options in rwanda
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3577801/
https://www.ncbi.nlm.nih.gov/pubmed/23437040
http://dx.doi.org/10.1371/journal.pone.0054180
work_keys_str_mv AT binagwahoagnes preventionofmothertochildtransmissionofhivcosteffectivenessofantiretroviralregimensandfeedingoptionsinrwanda
AT pegurrielisabetta preventionofmothertochildtransmissionofhivcosteffectivenessofantiretroviralregimensandfeedingoptionsinrwanda
AT drobacpeterc preventionofmothertochildtransmissionofhivcosteffectivenessofantiretroviralregimensandfeedingoptionsinrwanda
AT mugwanezaplacidie preventionofmothertochildtransmissionofhivcosteffectivenessofantiretroviralregimensandfeedingoptionsinrwanda
AT stulacsaran preventionofmothertochildtransmissionofhivcosteffectivenessofantiretroviralregimensandfeedingoptionsinrwanda
AT wagnerclairem preventionofmothertochildtransmissionofhivcosteffectivenessofantiretroviralregimensandfeedingoptionsinrwanda
AT karemacorine preventionofmothertochildtransmissionofhivcosteffectivenessofantiretroviralregimensandfeedingoptionsinrwanda
AT tsaguelandry preventionofmothertochildtransmissionofhivcosteffectivenessofantiretroviralregimensandfeedingoptionsinrwanda